SEC Info℠  
    Home      Search      My Interests      Help      Sign In      Please Sign In

Masimo Corp. – ‘DEFR14A’ on 5/24/23

On:  Wednesday, 5/24/23, at 9:49pm ET   ·   As of:  5/25/23   ·   Accession #:  937556-23-99   ·   File #:  1-33642

1 Reference:  By:  Masimo Corp. – ‘DEFA14A’ on 4/2/24

Find Words in Filings emoji
 		  in    Show  and   ↓Hints

  As Of               Filer                 Filing    For·On·As Docs:Size

 5/25/23  Masimo Corp.                      DEFR14A               12:1.5M

Revised Definitive Proxy Soliciting Material   —   Schedule 14A

Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: DEFR14A     Revised Definitive Proxy Soliciting Material        HTML    464K 
 6: R1          Cover                                               HTML     16K 
 7: R2          Pay vs Performance Disclosure                       HTML    191K 
10: XML         IDEA XML File -- Filing Summary                      XML     15K 
 8: XML         XBRL Instance -- masi-20230525_htm                   XML    322K 
 9: EXCEL       IDEA Workbook of Financial Report Info              XLSX     16K 
 3: EX-101.DEF  XBRL Definitions -- masi-20230525_def                XML     20K 
 4: EX-101.LAB  XBRL Labels -- masi-20230525_lab                     XML     30K 
 5: EX-101.PRE  XBRL Presentations -- masi-20230525_pre              XML     20K 
 2: EX-101.SCH  XBRL Schema -- masi-20230525                         XSD     17K 
11: JSON        XBRL Instance as JSON Data -- MetaLinks              101±   126K 
12: ZIP         XBRL Zipped Folder -- 0000937556-23-000099-xbrl      Zip    221K

‘DEFR14A’   —   Revised Definitive Proxy Soliciting Material

This is an HTML Document rendered as filed.  [ Alternative Formats ]

 iX:   C:  C: 
  masi-20230525  
 i DEFR14A i 0000937556 i false i 
Year
Summary
 Compensation
 Table Total for
 PEO(1)
Compensation
 Actually Paid to
 PEO(2)
Average Summary
 Compensation
 Table Total for
 Non-PEO NEOs(3)
Average
 Compensation
 Actually Paid to
 Non-PEO NEOs(4)
Value of Initial Fixed $100 Investment Based On:
Net Income
 (in Millions)(7)
Adjusted Product
 Revenue
(in Millions)(8)
Total Shareholder
 Return(5)
Nasdaq Medical
Device Index
 Total Shareholder
 Return(6)
2022$16,511,436 $(34,048,610)$5,716,969 $(2,544,510)$92.76 $123.96 $229.6 $2,035.8
202116,219,278 4,616,920 2,291,362 1,773,597 183.57 153.11 240.3 1,239.2
202015,493,723 118,009,752 2,285,362 13,969,285 168.27 122.92 196.2 1,143.7
 i 16,511,436 i 34,048,610 i 5,716,969 i 2,544,510 i 92.76 i 123.96 i 229.6 i 2,035.8 i 16,219,278 i 4,616,920 i 2,291,362 i 1,773,597 i 183.57 i 153.11 i 240.3 i 1,239.2 i 15,493,723 i 118,009,752 i 2,285,362 i 13,969,285 i 168.27 i 122.92 i 196.2 i 1,143.7 i The dollar amounts reported in this column are the amounts of total compensation reported for Mr. Kiani, our CEO and PEO, for each corresponding year in the “Total” column of the Summary Compensation Table. Refer to “Executive Compensation — Executive Compensation Tables — Summary Compensation Table.” for additional information. i Mr. Kiani i The dollar amounts reported in this column represent the amount of the CAP to Mr. Kiani, as computed in accordance with Item 402(v) of Regulation S-K. The dollar amounts do not reflect the actual amount of compensation earned by or paid to Mr. Kiani during the applicable year. In accordance with the requirements of Item 402(v) of Regulation S-K, the following adjustments were made to Mr. Kiani’s total compensation reported in the Summary Compensation Table for each year to determine the CAP:
YearReported Summary
 Compensation Table
 Total for PEO
Reported Value of
Equity Awards(a)
Equity Award
 Adjustments(b)
Reported Change in
 Actuarial Present Value
 of Pension Benefits		Pension Benefit
 Adjustments		Compensation Actually
 Paid to PEO
2022$16,511,436 $13,199,943 $(37,360,103)$— $— $(34,048,610)
202116,219,278 11,999,370 397,012 — — 4,616,920 
202015,493,723 11,999,886 114,515,916 — — 118,009,752 
______________
(a)    The grant date fair value of equity awards represents the total of the amounts reported in the “Stock Awards” and “Option Awards” columns in the Summary Compensation Table for the applicable year.
(b)    The equity award adjustments for each applicable year include the addition (or subtraction, as applicable) of the following: (i) the year-end fair value of any equity awards granted in the applicable year that are outstanding and unvested as of the end of the year; (ii) the amount of change as of the end of the applicable year (from the end of the prior fiscal year) in fair value of any awards granted in prior years that are outstanding and unvested as of the end of the applicable year; (iii) for awards that are granted and vest in same applicable year, the fair value as of the vesting date; (iv) for awards granted in prior years that vest in the applicable year, the amount equal to the change as of the vesting date (from the end of the prior fiscal year) in fair value; (v) for awards granted in prior years that are determined to fail to meet the applicable vesting conditions during the applicable year, a deduction for the amount equal to the fair value at the end of the prior fiscal year; and (vi) the dollar value of any dividends or other earnings paid on stock or option awards in the applicable year prior to the vesting date that are not otherwise reflected in the fair value of such award or included in any other component of total compensation for the applicable year. The valuation assumptions used to calculate fair values did not materially differ from those disclosed at the time of grant. The amounts deducted or added in calculating the equity award adjustments are as follows:
YearYear End Fair Value
 of Equity Awards		Year over Year
 Change in Fair Value
 of Outstanding and
 Unvested Equity
 Awards		Fair Value as of
 Vesting Date of
 Equity Awards
 Granted and Vested
 in the Year		Year over Year
 Change in Fair Value
 of Equity Awards
 Granted in Prior
Years that Vested in
 the Year		Fair Value at the End
of the Prior Year of
  Equity Awards that
 Failed to Meet
 Vesting Conditions
in the Year		Value of Dividends or
 other Earnings Paid
 on Stock or Option
 Awards not
 Otherwise Reflected
 in Fair Value or
 Total Compensation		Total Equity
Award Adjustments
2022$22,291,180 $(36,726,578)$— $(22,924,705)$— $— $(37,360,103)
202125,082,098 (6,301,272)— (18,383,814)— — 397,012 
202031,481,893 68,792,082 — 14,241,941 — — 114,515,916 
_______________
(3)     The dollar amounts reported in this column represent the average of the amounts reported for the Company’s NEOs as a group (excluding Mr. Kiani) in the “Total” column of the Summary Compensation Table in each applicable year. The names of each of the Non-PEO NEOs included for purposes of calculating the average amounts in each applicable year are as follows: (i) for fiscal year 2022, Micah Young, Bilal Muhsin, Tao Levy, Tom McClenahan and Kevin Duffy and (ii) for fiscal year 2021, and 2020, Micah Young, Bilal Muhsin, Tao Levy and Tom McClenahan. Refer to “Executive Compensation — Executive Compensation Tables — Summary Compensation Table” for additional information.
 i 16,511,436 i 13,199,943 i 37,360,103 i — i — i 34,048,610 i 16,219,278 i 11,999,370 i 397,012 i — i — i 4,616,920 i 15,493,723 i 11,999,886 i 114,515,916 i — i — i 118,009,752 i 22,291,180 i 36,726,578 i — i 22,924,705 i — i — i 37,360,103 i 25,082,098 i 6,301,272 i — i 18,383,814 i — i — i 397,012 i 31,481,893 i 68,792,082 i — i 14,241,941 i — i — i 114,515,916 i The dollar amounts reported in this column represent the average amount of the CAP to the Non-PEO NEOs as a group, as computed in accordance with Item 402(v) of Regulation S-K. The dollar amounts do not reflect the actual average amount of compensation earned by or paid to the Non-PEO NEOs as a group during the applicable year. In accordance with the requirements of Item 402(v) of Regulation S-K, the following adjustments were made to average total compensation reported in the Summary Compensation Table for the Non-PEO NEOs as a group for each year to determine the CAP, using the same methodology described above in Note (2):
YearAverage Reported
 Summary Compensation
 Table Total for
 Non-PEO NEOs		Less:
Average Reported Value
 of Equity Awards
Average Equity
Award Adjustments(a)
Average Reported Change
 in the Actuarial Present
 Value of Pension Benefits		Average Pension Benefit
 Adjustments		Average Compensation
 Actually Paid to
 Non-PEO NEOs
2022$5,716,969 $3,431,905 $(4,829,574)$— $— $(2,544,510)
20212,291,362 1,499,799 982,034 — — 1,773,597 
20202,285,362 1,499,941 13,183,864 — — 13,969,285 





(a)    The amounts deducted or added in calculating the total average equity award adjustments are as follows:
YearAverage Year End
Fair Value of Equity
 Awards		Year over Year
 Average Change in
 Fair Value of
 Outstanding and
 Unvested Equity
 Awards		Average Fair Value as
 of Vesting Date of
 Equity Awards
 Granted and Vested
 in the Year		Year over Year
 Average Change in
 Fair Value of Equity
 Awards Granted in
 Prior Years that
 Vested in the Year		Average Fair Value at
 the End of the Prior
 Year of Equity Awards that
 Failed to Meet Vesting
 Conditions in the Year		Average Value of
 Dividends of other
 Earnings Paid on
 Stock or Options
 Awards not
 Otherwise Reflected
 in Fair Value or
 Total Compensation		Total Average Equity
 Award Adjustments
2022$2,229,023 $(4,147,950)$— $(2,910,647)$— $— $(4,829,574)
20213,135,004 (332,549)— (1,820,421)— — 982,034 
20203,935,120 8,323,572 — 925,172 — — 13,183,864 
 i 5,716,969 i 3,431,905 i 4,829,574 i — i — i 2,544,510 i 2,291,362 i 1,499,799 i 982,034 i — i — i 1,773,597 i 2,285,362 i 1,499,941 i 13,183,864 i — i — i 13,969,285 i 2,229,023 i 4,147,950 i — i 2,910,647 i — i — i 4,829,574 i 3,135,004 i 332,549 i — i 1,820,421 i — i — i 982,034 i 3,935,120 i 8,323,572 i — i 925,172 i — i — i 13,183,864 i Cumulative TSR is calculated by dividing (i) the sum of the cumulative amount of dividends for the measurement period, assuming dividend reinvestment, and the difference between the Company’s stock price at the end and the beginning of the measurement period by (ii) the Company’s stock price at the beginning of the measurement period. i Represents the weighted peer group TSR, weighted according to the respective companies’ stock market capitalization at the beginning of each period for which a return is indicated. The peer group used for this purpose is the Nasdaq Medical Device Index. i The dollar amounts reported represent the amount of net income reflected in the Company’s audited financial statements for the applicable year. i While the Company uses numerous financial and non-financial performance measures for the purpose of evaluating performance for the Company’s compensation program, the Company has determined that Adjusted Product Revenue is the financial performance measure that, in the Company’s assessment, represents the most important performance measure (that is not otherwise required to be disclosed in the table) used by the Company to link the CAP to the Company’s NEOs, for the most recently completed fiscal year. i Adjusted Product Revenue i Adjusted Non-GAAP Operating Profit i 
CAP and Adjusted Product Revenue
As demonstrated by the below graph, the amount of CAP to Mr. Kiani and the average amount of CAP to the Company’s Non-PEO NEOs as a group is generally aligned with the Company’s Adjusted Product Revenue over the three year period presented in the table. While the Company uses numerous financial and non-financial performance measures for the purpose of evaluating performance for the Company’s compensation program, the Company has determined that Adjusted Product Revenue is the most important financial performance measure that is linked to the CAP for the PEO and the Non-PEO NEOs, for the most recently completed fiscal year. The Company utilizes Adjusted Product Revenue when setting goals in the Company’s incentive compensation plan. As described in more detail in the section “Executive Compensation—Compensation Discussion and Analysis,” the Company targets that approximately 75% of the value of total compensation awarded to the PEO and the Non-PEO NEOs consists of amounts determined under the Company incentive compensation plans to be comprised of performance-based RSUs and stock options.

 i 
CAP and Cumulative TSR
As demonstrated by the below graph, the amount of CAP to Mr. Kiani and the average amount of CAP to the Company’s Non-PEO NEOs as a group is aligned with the Company’s cumulative TSR over the three-year period presented in the table. The alignment of the CAP with the Company’s cumulative TSR over the period presented is because a significant portion of the CAP to Mr. Kiani and to the Non-PEO NEOs is comprised of equity awards. As described in more detail in the section “Executive Compensation—Compensation Discussion and Analysis,” the Company targets that approximately 75% of the value of total compensation awarded to the PEO and the Non-PEO be at-risk, which is comprised of equity awards, including performance-based RSUs and stock options.
 i 
CAP and Net Income
As demonstrated by the below graph, the amount of CAP to Mr. Kiani and the average amount of CAP to the Company’s Non-PEO NEOs as a group is generally aligned with the Company’s net income over the three-years presented in the graph. While the Company does not use net income as a performance measure in the overall executive compensation program, the measure of net income is correlated with the measure of Adjusted Product Revenue, which the Company uses in setting goals in the Company’s incentive compensation plans and the performance-based RSUs that are awarded to the PEO and Non-PEO NEOs. As described in more detail in the section “Executive Compensation—Compensation Discussion and Analysis,” the Company targets that approximately 61.8% of the value of total compensation awarded to the Non-PEO NEOs (and approximately 84.8% of the value of total compensation awarded to the PEO) consists of amounts determined under the Company long-term incentive compensation program.
 i 
CAP and Adjusted Non-GAAP Operating Profit
As demonstrated by the below graph, the amount of CAP to Mr. Kiani and the average amount of CAP to the Company’s Non-PEO NEOs as a group is generally aligned with the Company’s Adjusted Non-GAAP Operating Profit over the three-years presented in the table. While the Company uses numerous financial and non-financial performance measures for the purpose of evaluating performance for the Company’s compensation program, the Company has determined that Adjusted Non-GAAP Operating Profit is a financial performance measure that, in the Company’s assessment, represents a relevant measure used by the Company to evaluate CAP to the Company’s PEO and Non-PEO NEOs. The Company utilizes Adjusted Non-GAAP Operating Profit when setting goals in the Company’s incentive compensation plans. As described in more detail in the section “Executive Compensation—Compensation Discussion and Analysis,” the Company targets that approximately 61.8% of the value of total compensation awarded to the PEO (and approximately 84.8% of the value of the total compensation awarded to the Non-PEO NEOs) consists of amounts determined under the Company’s incentive compensation plan to be comprised of performance-based RSUs and stock options.
 i 
Relative TSR and Nasdaq Medical Equipment Index TSR
As demonstrated by the below graph, the Company’s cumulative TSR over the three year period presented in the table was 7%, while the cumulative TSR of the Nasdaq Medical Equipment Index, was 24% over the three years presented in the table. The Company’s cumulative TSR has historically outperformed the Nasdaq Medical Equipment Index during the three years presented in the graph, representing the Company’s superior financial performance as compared to the companies comprising the Nasdaq Medical Equipment Index. For more information regarding the Company’s performance and the companies that the Compensation Committee considers when determining compensation, refer to “Executive Compensation—Compensation Discussion and Analysis.”
 i 2,035.8 i 1,239.2 i 1,143.700009375562022-01-022022-12-31iso4217:USD00009375562021-01-032022-01-0100009375562019-12-292021-01-020000937556ecd:PeoMembermasi:AdjustmentEquityAwardsReportedValueMember2022-01-022022-12-310000937556ecd:PeoMembermasi:AdjustmentEquityAwardAdjustmentsMember2022-01-022022-12-310000937556ecd:PeoMembermasi:AdjustmentReportedChangeInActuarialPresentValueOfPensionBenefitsMember2022-01-022022-12-310000937556ecd:PeoMembermasi:AdjustmentPensionAdjustmentsMember2022-01-022022-12-310000937556ecd:PeoMembermasi:AdjustmentEquityAwardsReportedValueMember2021-01-032022-01-010000937556ecd:PeoMembermasi:AdjustmentEquityAwardAdjustmentsMember2021-01-032022-01-010000937556ecd:PeoMembermasi:AdjustmentReportedChangeInActuarialPresentValueOfPensionBenefitsMember2021-01-032022-01-010000937556ecd:PeoMembermasi:AdjustmentPensionAdjustmentsMember2021-01-032022-01-010000937556ecd:PeoMembermasi:AdjustmentEquityAwardsReportedValueMember2019-12-292021-01-020000937556ecd:PeoMembermasi:AdjustmentEquityAwardAdjustmentsMember2019-12-292021-01-020000937556ecd:PeoMembermasi:AdjustmentReportedChangeInActuarialPresentValueOfPensionBenefitsMember2019-12-292021-01-020000937556ecd:PeoMembermasi:AdjustmentPensionAdjustmentsMember2019-12-292021-01-020000937556ecd:PeoMembermasi:EquityAwardsGrantedDuringTheYearUnvestedMember2022-01-022022-12-310000937556ecd:PeoMembermasi:EquityAwardsGrantedInPriorYearsUnvestedMember2022-01-022022-12-310000937556ecd:PeoMembermasi:EquityAwardsGrantedDuringTheYearVestedMember2022-01-022022-12-310000937556ecd:PeoMembermasi:EquityAwardsGrantedInPriorYearsVestedMember2022-01-022022-12-310000937556ecd:PeoMembermasi:EquityAwardsThatFailedToMeetVestingConditionsMember2022-01-022022-12-310000937556ecd:PeoMembermasi:EquityAwardsValueOfDividendsAndOtherEarningsPaidMember2022-01-022022-12-310000937556ecd:PeoMembermasi:EquityAwardsGrantedDuringTheYearUnvestedMember2021-01-032022-01-010000937556ecd:PeoMembermasi:EquityAwardsGrantedInPriorYearsUnvestedMember2021-01-032022-01-010000937556ecd:PeoMembermasi:EquityAwardsGrantedDuringTheYearVestedMember2021-01-032022-01-010000937556ecd:PeoMembermasi:EquityAwardsGrantedInPriorYearsVestedMember2021-01-032022-01-010000937556ecd:PeoMembermasi:EquityAwardsThatFailedToMeetVestingConditionsMember2021-01-032022-01-010000937556ecd:PeoMembermasi:EquityAwardsValueOfDividendsAndOtherEarningsPaidMember2021-01-032022-01-010000937556ecd:PeoMembermasi:EquityAwardsGrantedDuringTheYearUnvestedMember2019-12-292021-01-020000937556ecd:PeoMembermasi:EquityAwardsGrantedInPriorYearsUnvestedMember2019-12-292021-01-020000937556ecd:PeoMembermasi:EquityAwardsGrantedDuringTheYearVestedMember2019-12-292021-01-020000937556ecd:PeoMembermasi:EquityAwardsGrantedInPriorYearsVestedMember2019-12-292021-01-020000937556ecd:PeoMembermasi:EquityAwardsThatFailedToMeetVestingConditionsMember2019-12-292021-01-020000937556ecd:PeoMembermasi:EquityAwardsValueOfDividendsAndOtherEarningsPaidMember2019-12-292021-01-020000937556ecd:NonPeoNeoMembermasi:AdjustmentEquityAwardsReportedValueMember2022-01-022022-12-310000937556ecd:NonPeoNeoMembermasi:AdjustmentEquityAwardAdjustmentsMember2022-01-022022-12-310000937556ecd:NonPeoNeoMembermasi:AdjustmentReportedChangeInActuarialPresentValueOfPensionBenefitsMember2022-01-022022-12-310000937556ecd:NonPeoNeoMembermasi:AdjustmentPensionAdjustmentsMember2022-01-022022-12-310000937556ecd:NonPeoNeoMembermasi:AdjustmentEquityAwardsReportedValueMember2021-01-032022-01-010000937556ecd:NonPeoNeoMembermasi:AdjustmentEquityAwardAdjustmentsMember2021-01-032022-01-010000937556ecd:NonPeoNeoMembermasi:AdjustmentReportedChangeInActuarialPresentValueOfPensionBenefitsMember2021-01-032022-01-010000937556ecd:NonPeoNeoMembermasi:AdjustmentPensionAdjustmentsMember2021-01-032022-01-010000937556ecd:NonPeoNeoMembermasi:AdjustmentEquityAwardsReportedValueMember2019-12-292021-01-020000937556ecd:NonPeoNeoMembermasi:AdjustmentEquityAwardAdjustmentsMember2019-12-292021-01-020000937556ecd:NonPeoNeoMembermasi:AdjustmentReportedChangeInActuarialPresentValueOfPensionBenefitsMember2019-12-292021-01-020000937556ecd:NonPeoNeoMembermasi:AdjustmentPensionAdjustmentsMember2019-12-292021-01-020000937556ecd:NonPeoNeoMembermasi:EquityAwardsGrantedDuringTheYearUnvestedMember2022-01-022022-12-310000937556ecd:NonPeoNeoMembermasi:EquityAwardsGrantedInPriorYearsUnvestedMember2022-01-022022-12-310000937556ecd:NonPeoNeoMembermasi:EquityAwardsGrantedDuringTheYearVestedMember2022-01-022022-12-310000937556ecd:NonPeoNeoMembermasi:EquityAwardsGrantedInPriorYearsVestedMember2022-01-022022-12-310000937556ecd:NonPeoNeoMembermasi:EquityAwardsThatFailedToMeetVestingConditionsMember2022-01-022022-12-310000937556ecd:NonPeoNeoMembermasi:EquityAwardsValueOfDividendsAndOtherEarningsPaidMember2022-01-022022-12-310000937556ecd:NonPeoNeoMembermasi:EquityAwardsGrantedDuringTheYearUnvestedMember2021-01-032022-01-010000937556ecd:NonPeoNeoMembermasi:EquityAwardsGrantedInPriorYearsUnvestedMember2021-01-032022-01-010000937556ecd:NonPeoNeoMembermasi:EquityAwardsGrantedDuringTheYearVestedMember2021-01-032022-01-010000937556ecd:NonPeoNeoMembermasi:EquityAwardsGrantedInPriorYearsVestedMember2021-01-032022-01-010000937556ecd:NonPeoNeoMembermasi:EquityAwardsThatFailedToMeetVestingConditionsMember2021-01-032022-01-010000937556ecd:NonPeoNeoMembermasi:EquityAwardsValueOfDividendsAndOtherEarningsPaidMember2021-01-032022-01-010000937556ecd:NonPeoNeoMembermasi:EquityAwardsGrantedDuringTheYearUnvestedMember2019-12-292021-01-020000937556ecd:NonPeoNeoMembermasi:EquityAwardsGrantedInPriorYearsUnvestedMember2019-12-292021-01-020000937556ecd:NonPeoNeoMembermasi:EquityAwardsGrantedDuringTheYearVestedMember2019-12-292021-01-020000937556ecd:NonPeoNeoMembermasi:EquityAwardsGrantedInPriorYearsVestedMember2019-12-292021-01-020000937556ecd:NonPeoNeoMembermasi:EquityAwardsThatFailedToMeetVestingConditionsMember2019-12-292021-01-020000937556ecd:NonPeoNeoMembermasi:EquityAwardsValueOfDividendsAndOtherEarningsPaidMember2019-12-292021-01-02000093755612022-01-022022-12-31000093755622022-01-022022-12-31



UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
SCHEDULE 14A
Proxy Statement Pursuant to Section 14(a) of the
Securities Exchange Act of 1934
(Amendment No. 1)
Filed by the Registrant  ý                                                 Filed by a Party other than the Registrant  o
Check the appropriate box:
oPreliminary Proxy Statement
oConfidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2))
oDefinitive Proxy Statement
ýDefinitive Additional Materials
oSoliciting Material under §240.14a-12
masimologo300x1a06.jpg
 i MASIMO CORPORATION
(Name of Registrant as Specified In Its Charter)
(Name of Person(s) Filing Proxy Statement, if other than the Registrant)
Payment of Filing Fee (Check all boxes that apply):
ýNo fee required.
oFee paid previously with preliminary materials.
o
Fee computed on table in exhibit required by Item 25(b) per Exchange Act Rules 14a-6(i)(1) and 0-11.















EXPLANATORY NOTE
This Amendment No. 1 (this “Amendment”) to the definitive proxy statement on Schedule 14A filed by Masimo Corporation (the “Company”) with the Securities and Exchange Commission on May 24, 2023 (the “Proxy Statement”) is being filed solely to amend and restate Appendix E to correct certain errors in Appendix E of the Proxy Statement. Other than amending and restating Appendix E, this Amendment does not modify or update any other disclosures presented in the Proxy Statement. The version of the Proxy Statement that will be mailed to the Company’s stockholders will include the corrected Appendix E.
D-1
Image136.jpg | 2023 Proxy Statement


APPENDIX E

SUPPLEMENTAL INFORMATION REGARDING PARTICIPANTS IN THE SOLICITATION

Masimo, its directors, its director nominees and certain of its executive officers and employees are participants in the solicitation of proxies in connection with the Annual Meeting. The following tables (“Directors and Nominees” and “Officers and Employees”) set forth the names and business addresses of our directors and director nominees and the names, present principal occupations and business addresses of our executive officers and employees who are considered to be “participants” in our solicitation of proxies from our stockholders in connection with the Annual Meeting (collectively, the “Participants”).

DIRECTORS AND NOMINEES
The principal occupations of our directors and director nominees are described in the section captioned “Our Board of Directors.” The names of our directors and director nominees are below. The business address of each of the directors and director nominees is 52 Discovery, Irvine, California 92618.
Name
Julie A. Shimer, Ph.D.
H Michael Cohen
Joe Kiani
Adam Mikkelson
Craig Reynolds

OFFICERS AND EMPLOYEES
The principal occupations of our executive officers and employees who are considered Participants are set forth below. The principal occupation refers to such person’s position with the Company and the business address for each person is 52 Discovery, Irvine, California 92618.
NameTitle
Joe KianiChief Executive Officer & Chairman of the Board
Micah YoungExecutive Vice President, Chief Financial Officer
Bilal MuhsinChief Operating Officer
Tao LevyExecutive Vice President, Business Development
Tom McClenahanExecutive Vice President, General Counsel & Corporate Secretary
Blair TripodiChief Operating Officer, Consumer Division
Eli KammermanVice President, Business Development and Investor Relations

INFORMATION REGARDING OWNERSHIP OF MASIMO’S SECURITIES BY PARTICIPANTS
The number of shares of common stock of the Company held as of March 31, 2023 by the Participants who are directors or executive officers is set forth in the section titled “Ownership of our Stock - Security Ownership of Certain Beneficial Owners and Management” of this Proxy Statement.
The following table sets forth the number of shares of common stock of the Company held as of March 31, 2023 by the employees of the Company that are not executive officers but who are deemed Participants in our solicitation of proxies. The Company is unaware of any Participant who owns any securities of the Company of record that such Participant does not own beneficially, except as described in this Proxy Statement.

E-1
Image136.jpg | 2023 Proxy Statement



NAMEAMOUNT AND NATURE OF BENEFICIAL OWNERSHIP
Eli Kammerman301
INFORMATION REGARDING TRANSACTIONS IN MASIMO’S SECURITIES BY PARTICIPANTS — LAST TWO YEARS
The following table sets forth information regarding purchases and sales of Masimo’s securities by each Participant from January 1, 2021 to May 24, 2023. Unless otherwise indicated, all transactions were in the public market or pursuant to our equity compensation plans and none of the purchase price or market value of these securities is represented by funds borrowed or otherwise obtained for the purpose of acquiring or holding such securities.
NameTransaction DateNumber of Direct SharesNumber of Indirect SharesAcquisition (A) / Disposition (D)*Transaction Code
Adam Mikkelson05/27/20217490AM
Adam Mikkelson05/27/20217490DM
Adam Mikkelson05/27/20219220AA
Adam Mikkelson01/10/20226000DS
Adam Mikkelson01/18/20226000DS
Adam Mikkelson01/24/20226000DS
Adam Mikkelson05/26/20229220AM
Adam Mikkelson05/26/20229220DM
Adam Mikkelson05/26/20221,4350AA
Craig B. Reynolds01/11/202110,0000AM
Craig B. Reynolds01/11/202110,0000DS
Craig B. Reynolds01/11/202110,0000DM
Craig B. Reynolds05/27/20217490AM
Craig B. Reynolds05/27/20217490DM
Craig B. Reynolds05/27/20219220AA
Craig B. Reynolds05/26/20229220AM
Craig B. Reynolds05/26/20229220DM
Craig B. Reynolds05/26/20221,4350AA
H Michael Cohen05/27/20217490AM
H Michael Cohen05/27/20217490DM
H Michael Cohen05/27/20219220AA
H Michael Cohen05/26/20229220AM
H Michael Cohen05/26/20229220DM
H Michael Cohen05/26/20221,4350AA
Joe E. Kiani01/02/202120,0000AM
Joe E. Kiani01/02/202120,0000DM
Joe E. Kiani01/07/202101,542DS (By Trust)
Joe E. Kiani01/08/2021052,698DS (By Trust)
Joe E. Kiani01/11/202109,034DS (By Trust)
Joe E. Kiani01/12/202103,403DS (By Trust)
Joe E. Kiani02/22/2021145,9440AA
Joe E. Kiani02/26/202139,5630AA
Joe E. Kiani10/26/202102,600DS (By Trust)
Joe E. Kiani10/26/2021027,332DS (By Trust)
Joe E. Kiani10/27/2021019,853DS (By Trust)
Joe E. Kiani10/29/2021018,967DS (By Trust)
E-2
Image136.jpg | 2023 Proxy Statement


Joe E. Kiani11/01/202103,429DS (By Trust)
Joe E. Kiani11/02/202108,223DS (By Trust)
Joe E. Kiani11/02/2021015,223DS (By Trust)
Joe E. Kiani11/03/20210200DS (By Trust)
Joe E. Kiani11/04/202104,173DS (By Trust)
Joe E. Kiani11/12/202108,549DS (By Trust)
Joe E. Kiani11/15/2021027,599DS (By Trust)
Joe E. Kiani11/16/202102,440DS (By Trust)
Joe E. Kiani11/17/2021032,597DS (By Trust)
Joe E. Kiani11/18/2021020,399DS (By Trust)
Joe E. Kiani11/19/202108,416DS (By Trust)
Joe E. Kiani01/01/202202DS (in Retirement Savings Plan)
Joe E. Kiani01/02/202220,0000AM
Joe E. Kiani01/02/202210,5610DF
Joe E. Kiani01/02/202220,0000DM
Joe E. Kiani02/14/202293,0320AA
Joe E. Kiani02/14/202248,9820DF
Joe E. Kiani02/22/202263,6210AA
Joe E. Kiani11/11/202201,201AP (By Trust)
Joe E. Kiani11/11/202202,969AP (By Trust)
Joe E. Kiani11/11/202202,514AP (By Trust)
Joe E. Kiani11/11/202201,100AP (By Trust)
Joe E. Kiani11/14/2022015,157AP (By Trust)
Joe E. Kiani11/14/2022016,537AP (By Trust)
Joe E. Kiani11/14/20220300AP (By Trust)
Joe E. Kiani12/15/202201,063AP (By Trust)
Joe E. Kiani12/15/202202,397AP (By Trust)
Joe E. Kiani12/15/202202,039AP (By Trust)
Joe E. Kiani12/15/202201,541AP (By Trust)
Joe E. Kiani03/03/202350,1610AA
Joe E. Kiani03/03/202326,4100DF
Joe E. Kiani03/03/202342,2510AA
Joe E. Kiani03/17/202342,7350DG
Joe E. Kiani03/17/2023042,735AG
Julie Ann Shimer05/27/20217490AM
Julie Ann Shimer05/27/20217490DM
Julie Ann Shimer05/27/20219220AA
Julie Ann Shimer05/26/20229220AM
Julie Ann Shimer05/26/20229220DM
Julie Ann Shimer05/26/20221,4350AA
Bilal Muhsin02/22/202114,5930AA
Bilal Muhsin02/26/20217,9120AA
Bilal Muhsin02/14/20229,3020AA
Bilal Muhsin02/22/202212,7240AA
Bilal Muhsin03/03/202310,0320AA
Bilal Muhsin03/03/20235,3020DF
E-3
Image136.jpg | 2023 Proxy Statement


Bilal Muhsin03/03/20238,8020AA
Blair Tripodi03/03/20236,7210AA
Micah W. Young02/22/202114,5930AA
Micah W. Young02/26/20213,9560AA
Micah W. Young04/08/20212,0870AM
Micah W. Young04/08/20212,0870DM
Micah W. Young04/08/20212,0870DS
Micah W. Young11/12/20213,7000DS
Micah W. Young02/14/20229,3020AA
Micah W. Young02/22/20236,3620AA
Micah W. Young03/03/20235,0160AA
Micah W. Young03/03/20232,6630DF
Micah W. Young03/03/20238,8020AA
Tao Levy02/22/202114,5930AA
Tao Levy02/26/20213,9560AA
Tao Levy12/06/20213,0000DS
Tao Levy02/14/20229,3020AA
Tao Levy02/22/20236,3620AA
Tao Levy03/03/20235,0160AA
Tao Levy03/03/20232,6720DF
Tao Levy03/03/20235,4410AA
Tom S. McClenahan01/02/20212,0000AM
Tom S. McClenahan01/02/20217860DF
Tom S. McClenahan01/02/20212,0000DM
Tom S. McClenahan02/22/202114,5930AA
Tom S. McClenahan02/26/20213,9560AA
Tom S. McClenahan04/30/20215000AP
Tom S. McClenahan05/03/20215000AP
Tom S. McClenahan05/11/20215000AP
Tom S. McClenahan01/02/20222,0000AM
Tom S. McClenahan01/02/20221,0840DF
Tom S. McClenahan01/02/20222,0000DM
Tom S. McClenahan02/14/20229,3020AA
Tom S. McClenahan02/22/20226,3620AA
Tom S. McClenahan03/03/20238,8020AA
Tom S. McClenahan03/03/20235,0160AA
Tom S. McClenahan03/03/20232,6680DF
Eli Kammerman2/25/20223380DM
Eli Kammerman2/25/202230DM
Eli Kammerman2/25/20226000DM
Eli Kammerman2/25/2022130DM
Eli Kammerman2/25/20227460DM
Eli Kammerman2/25/20223000DM
Eli Kammerman3/10/20221,6000DM
Eli Kammerman3/22/2022510AA
Eli Kammerman3/22/2022980AA
Eli Kammerman3/22/2022720AA
Eli Kammerman5/12/2022510DF
E-4
Image136.jpg | 2023 Proxy Statement


Eli Kammerman5/12/2022980DF
Eli Kammerman5/12/2022720DF
Eli Kammerman3/22/2023520AA
Eli Kammerman3/22/2023950AA
Eli Kammerman3/22/2023810AA
Eli Kammerman3/22/2023730AA
_____________
*Transaction Codes:
A:Grant, award, or other acquisition of securities from the company (such as an option)
D:Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
F:Payment of exercise price or tax liability by delivering or withholding securities
G:Bona fide gift form of any clauses
M:Exercise or conversion of derivative security
P:Open market or private purchase of non-derivative or derivative security
S:Open market or private sale of securities

MISCELLANEOUS INFORMATION REGARDING PARTICIPANTS IN THE SOLICITATION
Except as described in the proxy statement or this Appendix E, to Masimo’s knowledge: none of the Participants or their associates (i) during the past ten (10) years, has been convicted in a criminal proceeding (excluding traffic violations or similar misdemeanors); (ii) beneficially owns, directly or indirectly, any shares or other securities of Masimo or any of Masimo’s subsidiaries; or (iii) has a substantial interest, direct or indirect, by security holdings or otherwise, in any matter to be acted upon at the Annual Meeting. In addition, other than as set forth in this Appendix E or the proxy statement, neither Masimo nor any of the Participants has been within the past year party to any contract, arrangement or understanding with any person with respect to any of our securities, including, but not limited to, joint ventures, loan or option arrangements, puts or calls, guarantees against loss or guarantees of profit, division of losses or profits or the giving or withholding of proxies. Other than as set forth in this Appendix E or the proxy statement, none of the Participants or any of their associates has (i) any arrangements or understandings with any person with respect to any future employment by Masimo or its affiliates or with respect to any future transactions to which Masimo or any of its affiliates will or may be a party; or (ii) a direct or indirect material interest in any transaction or series of similar transactions since the beginning of Masimo’s last fiscal year or any currently proposed transactions, to which Masimo or any of its subsidiaries was or is to be a party in which the amount involved exceeded $120,000.
E-5
Image136.jpg | 2023 Proxy Statement

Dates Referenced Herein   and   Documents Incorporated by Reference

This ‘DEFR14A’ Filing    Date    Other Filings
Filed as of:5/25/23
Filed on:5/24/23ARS,  DEFC14A,  PRER14A
3/31/23
1/1/21
 List all Filings 

1 Subsequent Filing that References this Filing

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 4/02/24  Masimo Corp.                      DEFA14A                1:34K                                    EdgarAgents LLC/FA
↑Top
Filing Submission 0000937556-23-000099   –   Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)
Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
About — Privacy — Redactions — Help — Thu., May 2, 3:08:14.1am ET